治疗急性呼吸困难综合征的葡萄糖皮质类药物治疗:当前的概念
Yuanrui Zhao1, Zhun Yao1, Song Xu1
1Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Journal of intensive medicine
|September 23, 2024
概括
葡萄糖皮质类药物 (GCs) 在治疗急性呼吸窘迫综合征 (ARDS) - - 一种严重的肺部疾病方面表现有前途. 需要进一步的研究来确定ARDS患者的最佳GC使用,特别是在COVID-19大流行期间.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性呼吸窘迫综合征 (ARDS) 是一种危及生命的疾病,对全球健康产生重大影响.
- 目前的ARDS管理面临着由COVID-19大流行加剧的挑战,没有确定的特定药物治疗方法.
- 葡萄糖皮质类药物 (GCs) 正在研究它们在ARDS中的潜在治疗作用.
研究的目的:
- 审查目前对葡萄糖皮质体 (GC) 在ARDS中的作用机制的理解.
- 检查GC在ARDS管理中的临床应用和有效性.
- 为解决关于在ARDS中使用GC的持续辩论和未回答的问题,特别是在COVID-19的背景下.
主要方法:
- 对研究的文献综述 调查ARDS的葡萄糖皮质类药物.
- 对GC机制,剂量和患者结果的现有数据的分析.
- 综合与ARDS异质性相关的发现及其对GC治疗的影响.
主要成果:
- 该审查强调了ARDS复杂的病理生理学以及GCs的潜在好处.
- 在不同研究中,GC给药方案存在显著的变化,需要标准化.
- ARDS的异质性可能会影响外源性GC治疗的有效性.
结论:
- 葡萄糖皮质类药物代表了一种有希望的,但尚未完全确立的ARDS治疗选择.
- 进一步的研究对于确定ARDS患者最佳GC剂,剂量和持续时间至关重要.
- 了解ARDS异质性是定制GC治疗以改善临床结果的关键,特别是在COVID-19等大流行期间.
相关概念视频
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
227
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
227
01:26COPD: Management Using Bronchodilators and Corticosteroids
186
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
186
01:29Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
360
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98